South City reintroduces itself to Genentech

Dubbed an insider's look at the 2009 buyout of South San Francisco-based biotech giant Genentech by Roche, Genentech Chief Financial Officer Steve Krognes didn't disappoint at a BioExec Institute event last week.
But South San Francisco City Councilman Pedro Gonzalez may have provided the best insight into the fallout of the $47 billion deal and its impact on the Bay Area psyche.